Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Biocon's Malaysia Inspection Yields 6 Observations

Biocon's Malaysia Inspection Yields 6 Observations

Chemical Weekly 2018-03-29

Biocon has issued a statement to the stock exchanges that the US-FDA completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with six observations.

“As per the normal process, the company has already submitted the Corrective and Preventive Action Plan (CAPA) to address these observations to the regulator,” the Biocon spokesperson said on Feb 21, 2018.

 

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.